Data as of Nov 26
| +0.01 / +0.06%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 20.50, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a +16.54% increase from the last price of 17.59.
The current consensus among 8 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.